INSULIN Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The INSULIN Act of 2026 caps cost-sharing for selected insulin products at $35 per 30-day supply (or 25% of negotiated price, whichever is lower) for most health plans beginning in 2028, with no deductibles applied to these products. The bill also prohibits prior authorization and other medical management requirements on selected insulin products except for safety or quantity-limit reasons, establishes a resource center and hotline to help uninsured individuals access insulin assistance programs, and directs a GAO study on uninsured insulin users.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.